Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Dye

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44258   clinical trials with a EudraCT protocol, of which   7344   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    48 result(s) found for: Dye. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2018-002924-18 Sponsor Protocol Number: 1517-CL-1001 Start Date*: 2019-07-11
    Sponsor Name:Astellas Pharma Global Development, Inc. (APGD)
    Full Title: A Phase 1 Crossover Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet and Pediatric Azo Dye free Mini-tablet (Solid and Suspension)...
    Medical condition: Healthy Adult Volunteers (intended indication is anemia associated with chronic kidney disease (CKD))
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004851 10002272 Anemia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-004086-15 Sponsor Protocol Number: 1000 Start Date*: 2005-05-17
    Sponsor Name:University Hospital of Frankfurt, Department of Cardiology
    Full Title: Comparison of nephrotoxic effects of the contrast dyes iodixanol (iso-osmolar, non-ionic, dimer) and ioversol (low-osmolar, non-ionic, monomer) in patients with impaired renal function and severe h...
    Medical condition: Coronary angiography in patients with known coronary artery disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-005134-15 Sponsor Protocol Number: NL75722.041.20 Start Date*: 2021-03-25
    Sponsor Name:University Medical Center Utrecht
    Full Title: The bilateral sentinel node detection rate of fluorescent indocyanine green compared to 99mTc and blue dye in the sentinel node procedure in stage I-IIA cervical cancer
    Medical condition: Sentinel lymph node procedure for patients with early-stage cervical cancer
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004864 10008233 Cervical cancer stage I LLT
    21.1 100000004864 10008234 Cervical cancer stage II LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-004834-14 Sponsor Protocol Number: POLAR_2013 Start Date*: 2014-03-31
    Sponsor Name:
    Full Title: Treatment of port wine stains using Pulsed Dye Laser, Erbium Yag Laser and topical sirolimus in an open label pilot study (POLAR).
    Medical condition: Port Wine Stain
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-002244-25 Sponsor Protocol Number: ICG20 Start Date*: 2012-07-05
    Sponsor Name:Norfolk & Norwich University Hospital
    Full Title: Prospective feasibility study for the evaluation of indocyanine green and near-infrared imaging in sentinel lymph node biopsy for cutaneous melanoma patients: The "RED-GREEN-BLUE" melanoma study.
    Medical condition: Cutaneous Melanoma
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10025655 Malignant melanoma of skin LLT
    20.0 100000004865 10068478 Sentinel lymphadenectomy LLT
    Population Age: Adults, Elderly Gender:
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005788-28 Sponsor Protocol Number: ICG1 Start Date*: 2014-01-24
    Sponsor Name:Landeskrankenhaus Fedkirch
    Full Title: Influence of Body Mass Index on the identification rate of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer
    Medical condition: A feasibility study of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000509-96 Sponsor Protocol Number: NL71166.041.19 Start Date*: 2020-05-14
    Sponsor Name:Princess Maxima Center for pediatric oncology
    Full Title: Near-infrared fluorescence imaging using indocyanine green as an adjunct to improve standard-of-care sentinel lymph node procedure in pediatric patients with melanoma or sarcoma of head/neck/trunk,...
    Medical condition: Sentinel node procedure for pediatric patients with melanoma or sarcoma
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2014-003932-38 Sponsor Protocol Number: 50797 Start Date*: 2016-03-30
    Sponsor Name:VU University medical center (VUmc)
    Full Title: Advanced imaging in laparoscopic HIPEC for peritoneal carcinomatosis of colorectal orgin to improve cytoreduction; a feasibility study
    Medical condition: Peritoneal carcinomatosis from colorectal origin
    Disease: Version SOC Term Classification Code Term Level
    18.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10052358 Colorectal cancer metastatic PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-000729-28 Sponsor Protocol Number: GA28084 Start Date*: 2012-06-13
    Sponsor Name:Genentech, Inc.
    Full Title: MULTICENTER STUDY IN PATIENTS WITH CROHN?S DISEASE FOR CHARACTERIZATION OF MAGNETIC RESONANCE ENTEROGRAPHY ASSAYS FOR ASSESSMENT OF DISEASE ACTIVITY
    Medical condition: Investigation of magnetic resonance enterography (MRE) with/without dye for evaluation of disease status in Crohn's disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10017947 - Gastrointestinal disorders 10017969 Gastrointestinal inflammatory conditions HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-000888-16 Sponsor Protocol Number: 16-001 Start Date*: 2018-05-17
    Sponsor Name:Medical University of Vienna
    Full Title: Bronchoscopic indocyanine green fluorescence imaging for the evaluation of anastomotic healing after lung transplantation
    Medical condition: Anastomotic healing after lung transplantation
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-016743-18 Sponsor Protocol Number: ICG10 Start Date*: 2010-02-02
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust
    Full Title: A feasibility study of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer
    Medical condition: Primary breast cancer
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-007474-38 Sponsor Protocol Number: GreenLight Start Date*: 2009-03-17
    Sponsor Name:Leiden University Medical Center
    Full Title: GREEN LIGHT: Intra-operative fluorescent imaging of sentinel lymph nodes in breast cancer
    Medical condition: Breast cancer
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-001725-10 Sponsor Protocol Number: 13-001 Start Date*: 2014-01-24
    Sponsor Name:Medizinische Universität Wien
    Full Title: Bronchoscopic indocyanine green fluorescence imaging for the evaluation of tracheal perfusion after surgery
    Medical condition: Tracheal stenosis secondary to malign and benign conditions
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2012-000988-25 Sponsor Protocol Number: version4 Start Date*: 2012-04-27
    Sponsor Name:Gateshead Health NHS Trust Research & Development
    Full Title: To determine the feasibility of using Microbubble technology to detect sentinel nodes in vulvar cancer.
    Medical condition: Early stage vulvar cancer with no clinial or radiological evidence of lymph node metastases
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2012-000424-18 Sponsor Protocol Number: ICTUC/32/2012 Start Date*: 2012-10-26
    Sponsor Name:Imperial College London
    Full Title: A study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative lymphatic imaging and sentinel lymph node identification during standard surgical resection for colonic c...
    Medical condition: Bowel cancer
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10009944 Colon cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-004498-29 Sponsor Protocol Number: HN-ICG-IV-1 Start Date*: 2013-11-29
    Sponsor Name:Institut Jules Bordet
    Full Title: Near-Infrared fluorescence imaging during neck dissection in head and neck cancer patients after intravenous injection of Indocyanine Green (a feasibility study)
    Medical condition: Imaging of tumoral tissues and of lymph nodes to be resected in head and neck cancers
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022440-20 Sponsor Protocol Number: 10-PP-11 Start Date*: Information not available in EudraCT
    Sponsor Name:CHU de Nice
    Full Title: Traitements of angioma plans of the child by laser to pulsed colouring agent and Timolol (Néogel 0,1%).
    Medical condition: Angioma plans
    Disease: Version SOC Term Classification Code Term Level
    12.1 10002461 Angioma of skin LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2020-004627-16 Sponsor Protocol Number: 70233 Start Date*: 2020-11-25
    Sponsor Name:Helsinki University Hospital
    Full Title: Clinical Validation of Quantitative Flutemetamol PET/CT in Cardiac Amyloidosis
    Medical condition: Cardiac amyloidosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10007541 - Cardiac disorders 10007509 Cardiac amyloidosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-021815-18 Sponsor Protocol Number: IEOS562/510 Start Date*: 2011-06-16
    Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA
    Full Title: - Identification of the sentinel node in breast cancer with fluorescence lymphography using indocyanine green dye (ICG): pilot study.
    Medical condition: BREAST CANCER
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10057654 Breast cancer female PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-001889-14 Sponsor Protocol Number: Bubble2012 Start Date*: 2012-10-15
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust
    Full Title: MicroBubble detection and Ultrasound guided Biopsy of axillary Lymph nodes in patients with Early breast cancer.
    Medical condition: Diagnosis of lymph node metastases in patients with newly diagnosed breast cancer.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10057654 Breast cancer female PT
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006203 Breast cancer stage unspecified LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA